Go Pro

Assenagon Asset Management S.A. Lowers Position in Xylem Inc. $XYL

Xylem logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Assenagon Asset Management cut its Xylem stake by 50.7% in the second quarter, selling 149,972 shares and retaining 145,638 shares valued at approximately $17.2 million.
  • Xylem reported quarterly EPS of $1.46, beating analysts’ $1.34 estimate, while revenue reached $2.34 billion, up 1.5% year over year. The company maintained fiscal 2026 EPS guidance of $5.55–$5.70.
  • Analyst sentiment remains positive, with nine Buy ratings and six Holds producing a “Moderate Buy” consensus and an average price target of $154. Xylem also pays a quarterly dividend of $0.43, equivalent to a 1.4% annualized yield.
  • MarketBeat previews top five stocks to own in September.

Assenagon Asset Management S.A. lessened its stake in Xylem Inc. (NYSE:XYL - Free Report) by 50.7% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 145,638 shares of the industrial products company's stock after selling 149,972 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.06% of Xylem worth $17,216,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the stock. J. Stern & Co. LLP grew its stake in shares of Xylem by 12,326.6% in the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company's stock worth $6,189,132,000 after acquiring an additional 45,082,435 shares in the last quarter. Norges Bank bought a new position in shares of Xylem during the fourth quarter valued at about $361,012,000. SEB Asset Management AB purchased a new position in Xylem during the first quarter worth about $66,700,000. Balyasny Asset Management L.P. grew its position in Xylem by 346.2% in the 3rd quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company's stock worth $105,160,000 after purchasing an additional 553,152 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. bought a new stake in Xylem in the 2nd quarter worth about $64,407,000. Hedge funds and other institutional investors own 87.96% of the company's stock.

Xylem Price Performance

Xylem stock opened at $120.95 on Tuesday. The business's 50 day simple moving average is $116.57 and its 200 day simple moving average is $121.08. Xylem Inc. has a 12 month low of $105.29 and a 12 month high of $154.27. The company has a market cap of $28.24 billion, a price-to-earnings ratio of 28.80, a PEG ratio of 1.67 and a beta of 1.02. The company has a current ratio of 1.61, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23.

Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.12. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The business had revenue of $2.34 billion during the quarter, compared to the consensus estimate of $2.34 billion. During the same period last year, the business posted $1.26 earnings per share. The business's revenue for the quarter was up 1.5% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Sell-side analysts forecast that Xylem Inc. will post 5.67 EPS for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date was Thursday, May 28th. Xylem's payout ratio is currently 40.95%.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Jefferies Financial Group raised shares of Xylem from a "hold" rating to a "buy" rating and lifted their target price for the stock from $130.00 to $140.00 in a research report on Thursday, June 25th. Royal Bank Of Canada upped their target price on Xylem from $159.00 to $164.00 and gave the company an "outperform" rating in a report on Wednesday, July 29th. Mizuho increased their price target on Xylem from $124.00 to $130.00 and gave the company a "neutral" rating in a research report on Wednesday, July 29th. Weiss Ratings reiterated a "hold (c)" rating on shares of Xylem in a report on Wednesday, August 5th. Finally, UBS Group boosted their price objective on Xylem from $129.00 to $135.00 and gave the stock a "neutral" rating in a research report on Thursday, July 30th. Nine research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $154.00.

Check Out Our Latest Stock Report on Xylem

About Xylem

(Free Report)

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Featured Articles

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines